From new KRAS and HER2 inhibitors to home-administered immunotherapy, recent trials mark a turning point in how metastatic lung cancer is managed.

Scientists at the Cancer Research Manchester Institute have created a new model of Lung Squamous Cell Carcinoma (LUSC), a common type of lung cancer, to study the development, activity, and ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Dame Esther Rantzen has said it would be “lovely” to meet her late husband Desmond Wilcox again in heaven, as she confirmed that her life-extending wonder drug has stopped working. The That’s Life ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas—tiny clumps of immune cells that form in response to ...